We all know the huge issue plastic is causing in our oceans today, but as it turns out this floating waste poses yet another danger: toxic heavy metals.
Over the last 20 years, Cisbio has become a leading Life Sciences company which develops, manufactures, and markets high quality kits and reagents for the drug discovery and life science markets used by pharmaceutical, biotechnology, academia and contract research organizations across the globe.
PerkinElmer's role in the historic Cassini spacecraft mission to Saturn.
New research by PerkinElmer confirms that PD-L1 protein expression levels in human breast cancer cells can be quickly and accurately assessed directly with the AlphaLISA human PD-L1 assay.
The Australian Institute of Marine Science (AIMS) is helping to sustain and restore damage to ecosystems due to a changing climate and microplastics contamination in the Great Barrier Reef.
North York General Hospital researchers have developed an Enhanced First Trimester Screen that is faster, less costly, but just as accurate as the standard Integrated Prenatal Screening protocol in detecting the risk for Down syndrome and Trisomy 18. The new test was developed with the help of PerkinElmer and is now in use in Ontario, Canada.
When it comes to feeding the world, we face a serious problem. Every second of every day, five new lives join the more than 7.5 billion people currently inhabiting our planet.
A group of scientists at the Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) have developed a new microscopy technique for blood cells that saves time, money, and, most importantly, is already helping to uncover new immunotherapy treatments for cancer.
Carl Carnagey, founder and CEO of Juniper Analytics, is the first to admit he totally underestimated what it would take for his startup to earn accreditation as an official cannabis testing lab in Oregon back in 2015.
Scientist undertakes historical assessment of the Tennessee River’s water quality with the help of PerkinElmer.